by TractManager | Apr 28, 2023 | Emerging Technology Report
Vowst (fecal microbiota spores, live-brpk; Seres Therapeutics Inc.) is an oral capsule containing fecal microbiota spores indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial...
by TractManager | Apr 27, 2023 | Emerging Technology Report
Pentosan polysulfate sodium (proposed name, Zilosul) is a subcutaneously injected semisynthetic glucosaminoglycan under investigation for treatment of knee osteoarthritis.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Apr 26, 2023 | Emerging Technology Report
Tofersen (Qalsody; Biogen) is an intrathecally administered antisense oligonucleotide indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS).If you have a Hayes login, click...
by TractManager | Apr 25, 2023 | Molecular Test Assessment
This report evaluates the clinical validity and clinical utility of the GeneStrat targeted genomic test (Biodesix Inc.).If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Apr 25, 2023 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment is evaluation of the effectiveness and safety of prostatic artery embolization (PAE) compared with open prostatectomy and minimally invasive approaches to treat moderate-to-severe benign prostatic...
Recent Comments